Shiro Akinaga
Directeur Général chez NANO MRNA CO.,LTD.
Fortune : 87 208 $ au 31/05/2024
Provenance du réseau au premier degré de Shiro Akinaga
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 8 | |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan.
4
| Subsidiary | Biotechnology | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Shiro Akinaga via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Tokyo | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Whiz Partners, Inc.
 Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Investment Managers | Chief Operating Officer Founder Private Equity Investor | |
Braizon Therapeutics, Inc.
 Braizon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Braizon Therapeutics, Inc. is a Japanese company that engages in researching and developing drugs. The company was founded in 2015 by Mariko Tosu. The CEO is Bunichi Wanibuchi. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| CELLSEED INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| ADVANCED MEDIA, INC. | Packaged Software | Director/Board Member Director/Board Member | |
| ALBERT | Packaged Software | Director/Board Member Director/Board Member | |
| AXEL MARK INC. | Advertising/Marketing Services | Director/Board Member Director/Board Member | |
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative, Inc. (FTI) is a Venture Capital firm, a subsidiary of Life Science Management, Inc. founded in 2004 by Koichi Ashida and Hiromichi Kimura. Fast Track Initiative, Inc. is headquartered in Tokyo with additional office in the Unites States. | Investment Managers | Founder Private Equity Investor | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Children's Mercy Hospital
 The Children's Mercy Hospital Hospital/Nursing ManagementHealth Services The Children's Mercy Hospital provides pediatric health care services. It offers abdominal pain program, adolescent medicine, anesthesiology, bioethics, bone marrow transplantation, burn and trauma care, cardiology, child abuse and neglect, cleft palate and craniofacial, dentistry, dermatology, down syndrome clinic, eating disorders center, endocrinology and diabetes, epilepsy center, fetal health center, gastroenterology, genetics, gynecology, hand clinic and surgery, hematology, heart center, imaging, kidney and liver transplant, medical imaging, neonatology, neurology, nutrition services, ophthalmology, pain management, pathology and laboratory medicine, pharmacology, radiology, respiratory care, sexual differentiation treatment, sleep disorders program, surgery, telemedicine, urgent care, urologic surgery, and weight management services. The company was founded in June 1897 and is headquartered in Kansas City, MO. | Hospital/Nursing Management | Corporate Officer/Principal | |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| LAWSON, INC. | Food Retail | Corporate Officer/Principal | |
| ENTRUST INC. | Miscellaneous Commercial Services | Director/Board Member | |
| PT MIDI UTAMA INDONESIA TBK | Food Retail | Director/Board Member | |
| Hokkaido University | College/University | Undergraduate Degree | |
Modulus Discovery, Inc.
 Modulus Discovery, Inc. BiotechnologyHealth Technology Modulus Discovery, Inc. preclinical stage drug Discovery Company. It is focused on rapid design and generation of small molecule clinical candidates for disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The company was founded by Shun Roy Kimura And Kazuki Ohno and is headquartered in Minato-ku, Japan. | Biotechnology | Director/Board Member | |
| MODALIS THERAPEUTICS CORPORATION | Biotechnology | Director/Board Member | |
PuREC KK
 PuREC KK BiotechnologyHealth Technology PuREC KK is a company based in Japan that aims to revolutionize the future of regenerative medicine by developing a high-purity mesenchymal stem cell culture technology called REC (Rapidly Expanding Cell). REC has approximately 1000 times more pharmacological efficacy in terms of proliferation and differentiation compared to normal mesenchymal stem cells, making it effective in treating a wide range of diseases. The Japanese company was founded in 2016 by Shotai Kobayashi. | Biotechnology | Director/Board Member | |
Fimecs, Inc.
 Fimecs, Inc. Miscellaneous Commercial ServicesCommercial Services Fimecs, Inc. is a technology company based in Fujisawa, Japan. Fimecs was ranked second in the world by KPMG Private Enterprise's Tech Innovator 2022. The Japanese company was founded in 2018 by Yusuke Tominari and Kanae Kaba, with Yusuke Tominari serving as the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
UTokyo Innovation Platform Co.,Ltd.
 UTokyo Innovation Platform Co.,Ltd. Investment ManagersFinance UTokyo Innovation Platform Co.,Ltd. (UTokyo IPC) is a Venture Capital firm, a subsidiary of University of Tokyo founded in 2016. UTokyo Innovation Platform Co.,Ltd. is headquartered in Tokyo. | Investment Managers | Chief Investment Officer | |
Adriakaim, Inc.
 Adriakaim, Inc. Medical SpecialtiesHealth Technology Adriakaim, Inc. manufactures and sells medical and health-related equipment. The company is based in Tokyo, Japan. Additionally, the Japanese company provides management and technology strategy consulting services. The company was founded in 2018 by Masatoshi Kobayashi, Hiroyuki Imabayashi. | Medical Specialties | Director/Board Member | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Life Science Management, Inc.
 Life Science Management, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Management, Inc. provides consulting services for businesses in the life science and healthcare industries. The Japanese company's focus is on helping these businesses to succeed and grow. | Miscellaneous Commercial Services | President | |
Astellas Venture Management LLC
 Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member | |
Monsanto Japan Ltd.
 Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The company is based in Tokyo, Japan. | Chemicals: Agricultural | President | |
HuBit Genomix KK
 HuBit Genomix KK Miscellaneous Commercial ServicesCommercial Services HuBit Genomix KK is a Japanese pharmaceutical development company that conducts clinical trials and research on pharmaceuticals to develop diagnostic drugs. The company is based in Tokyo, Japan. The company analyzes and utilize valuable information to create "diagnosis methods" and "pharmaceuticals" that satisfy medical amenities. HuBit Genomix KK was acquired by Celera Group on March 20, 2001. | Miscellaneous Commercial Services | President | |
| FUJI ELECTRONICS CO., LTD. | Electronics Distributors | Comptroller/Controller/Auditor | |
| Tokyo Women's Medical University | College/University | Corporate Officer/Principal | |
| Kawasaki Institute of Industrial Promotion | Director/Board Member | ||
| Innovation Center of Nanomedicine | President | ||
| NISSAN CHEMICAL CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
Carus Animal Health Ltd.
 Carus Animal Health Ltd. Miscellaneous Commercial ServicesCommercial Services Carus Animal Health Ltd. engages in the research and development of veterinary solutions. It focuses on veterinary medicine, life sciences, pharmaceuticals, diagnostics, and medical devices. The company was founded in June 2017 and is headquartered in High Wycombe, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| CRI MIDDLEWARE CO., LTD. | Packaged Software | Director/Board Member | |
Glamo, Inc.
 Glamo, Inc. Computer CommunicationsElectronic Technology Glamo, Inc. engages in IoT platform, system license, and hardware original equipment manufacturer (OEM) businesses. Its products include iRemocon and Glamo Smart Lock. The company was founded by Isao Goto on February 2, 2011 and is headquartered in Tokyo, Japan. | Computer Communications | Director/Board Member | |
| KIDSWELL BIO CORPORATION | Biotechnology | Director/Board Member | |
| CARNA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
ActualEyes, Inc.
 ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Packaged Software | Director/Board Member |
Statistiques
Internationale
| Japon | 35 |
| Etats-Unis | 5 |
| Royaume-Uni | 3 |
| Indonésie | 2 |
Sectorielle
| Health Technology | 13 |
| Commercial Services | 9 |
| Finance | 5 |
| Technology Services | 5 |
| Consumer Services | 4 |
Opérationnelle
| Director/Board Member | 48 |
| President | 7 |
| Corporate Officer/Principal | 7 |
| Private Equity Investor | 7 |
| Independent Dir/Board Member | 6 |
Relations les plus connectées
- Bourse
- Insiders
- Shiro Akinaga
- Connexions Sociétés
